ChromaTan Wins $2.5M FDA Contract to Develop Integrated Continuous Purification Platform

ChromaTan has won a $2.5 million FDA contract to develop an integrated, continuous downstream purification platform for production of monoclonal antibodies (mAbs).The two-year project will entail process development, design, and testing of the company’s column-free platform, called Continuous Countercurrent Tangential Chromatography (CCTC™). The multiunit operation process train is designed to continuously purify a mAb harvested from a Chinese hamster ovary (CHO) cell-based bioreacto